IBSA is a major pharmaceutical company specializing primarily in the development of hyaluronic acid-based medical devices and raw materials.


About the manufacturer

IBSA, or Institute Biochemical SA, was established in 1945 by a group of Swiss biologists and has since developed extensive expertise in pharmaceutical technology and research. With its innovative solutions, IBSA is present in more than 90 countries on 5 continents, including Europe, China, and the United States. IBSA Pharma Inc, a prominent player in the field of reproductive medicine and a global leader in hyaluronic acid-based product research and production, controls the whole supply chain, from the biotechnological production of hyaluronate to the manufacturing of ready-to-use pre-filled syringe vials for intra-articular injections — and more.

Manufacturer’s brands

IBSA Pharma manufactures Profhilo, a unique and highly effective treatment for skin rejuvenation. Profhilo is the first BDDE-free stabilized injectable hyaluronic acid (HA) product indicated for addressing skin laxity. Profhilo represents a new injectable category known as bioremodeling, as it is neither a commonly known dermal filler nor a biorevitalizer. It boosts and hydrates the skin while treating the aging and sagging tissue thanks to one of the highest HA concentrations on the market (32 mg/ml).

You can buy IBSA Pharma products from Major Medical Solutions online store. Profhilo is available for purchase at the most reasonable wholesale price.

Manufacturer’s strengths

IBSA is deeply committed to improving the quality of its patients’ life and preventing and curing diseases through innovative products with proven superior efficacy. IBSA manufactures all of its products in-house under GMP standards, with all manufacturing stages managed by vertically integrated processes.